Cefpirome

• UNSPSC Description:

  Cefpirome (HR 810) is a fourth generation cephalosporin. Cefpirome shows antibacterial activity. Cefpirome also has in vitro activity against Streptococcus pneumoniae[1].

• Target Antigen:

  Antibiotic; Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/cefpirome.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1[C@@H](NC(/C(C2=CSC(N)=N2)=N\OC)=O)[C@@]3([H])SCC(C[N+]4=CC=CC5=C4CCC5)=C(C([O-])=O)N13

• Molecular Weight:

  514.58

• References & Citations:

  [1]Wiseman LR, et al. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia. Drugs. 1997 Jul;54(1):117-40.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  84957-29-9